Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Medical Device Alert: IV extension sets with multiple ports and vented caps. Various manufacturers (MDA/2010/068)

Document details:

Type: Medical Device Alert
Series No: MDA/2010/068
Audience: Healthcare professionals
Published: 6 September 2010 at 14:00
Format: Electronic only
Size: A4
Pages: 4
Price: Free
ISBN/ISSN:
Author:
Copyright: Crown
   

Help viewing PDFs:

Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.

Immediate action

Ref: MDA/2010/068 | Issued: 6 September 2010 at 14:00

  1. England
  2. Northern Ireland
  3. Scotland
  4. Wales
  5. Device
  6. Problem
  7. Action
  8. Distribution
  9. Feedback

If you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2010/068 or 2010/007/029/601/006 .

Technical aspects
Louise Mulroy or Nicole Small
Medicines & Healthcare products Regulatory Agency
Market Towers
1 Nine Elms Lane
London SW8 5NQ

Tel: 020 7084 3344 or 3310
Fax: 020 7084 3209
Email: louise.mulroy@mhra.gsi.gov.uk 
nicole.small@mhra.gsi.gov.uk

Clinical aspects
Dr Susanne Ludgate
Medicines & Healthcare products Regulatory Agency
Market Towers 
1 Nine Elms Lane
London SW8 5NQ

Tel:      020 7084 3123
Fax:     020 7084 3111
Email:  susanne.ludgate@mhra.gsi.gov.uk

How to report adverse incidents
Please report via our website http://www.mhra.gov.uk
Further information about CAS can be found at https://www.cas.dh.gov.uk/Home.aspx 

Alerts in Northern Ireland will continue to be distributed via the NI SABS system. Enquiries and adverse incident reports in Northern Ireland should be addressed to:

Northern Ireland Adverse Incident Centre
Health Estates Investment Group
Room 17
Annex 6
Castle Buildings
Stormont Estate
Dundonald BT4 3SQ

Tel: 02890 523 704
Fax: 02890 523 900
Email:   NIAIC@dhsspsni.gov.uk
http://www.dhsspsni.gov.uk/index/hea/niaic.htm

How to report adverse incidents in Northern Ireland
Please report directly to NIAIC, further information can be found on our website http://www.dhsspsni.gov.uk/niaic
Further information about SABS can be found at http://sabs.dhsspsni.gov.uk/

Enquiries and adverse incident reports in Scotland should be addressed to:
Incident Reporting and Investigation Centre
Health Facilities Scotland
NHS National Services Scotland
Gyle Square
1 South Gyle Crescent
Edinburgh EH12 9EB

Tel: 0131 275 7575
Fax: 0131 314 0722
Email:   nss.iric@nhs.net
http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/

Enquiries in Wales should be addressed to:
Dr Sara Hayes
Senior Medical Officer
Medical Device Alerts
Welsh Assembly Government
Cathays Park
Cardiff CF10 3NQ

Tel: 029 2082 3922
Email: Haz-Aic@wales.gsi.gov.uk

IV extension sets with multiple ports and vented caps.

Various manufacturers

 

IV extension set with multiple ports and vented caps. (MDA/2010/068)

 

An example of a vented cap

An example of a vented cap (MDA/2010/068)

 

An incident has been reported where a patient suffered a stroke when an IV extension set, which had a vented cap attached to its Y-port, was connected to a central line.

Manufacturers use vented caps to allow the ethylene oxide gas to penetrate and then exit the IV extension set during the sterilisation process. If these sets are put into use with the vented caps still in place, air can enter the line and pose a risk of air embolism and death.

  • Ensure that IV extension sets are inspected to identify any vented caps prior to connecting them to a patient.
  • Do not leave vented caps on unused ports; replace immediately with a non-vented cap or appropriate alternative. If in doubt, replace the cap.
  • Be aware that there are alternative devices available, which are supplied with non-vented caps.

This MDA has been distributed to:

  • NHS trusts in England (Chief Executives)
  • Health Protection Agency (HPA) (Directors)
  • HSC trusts in Northern Ireland (Chief Executives)
  • NHS boards in Scotland (Chief Executives)
  • NHS boards and trusts in Wales (Chief Executives)
  • Primary care trusts in England (Chief Executives)

Onward distribution
Please bring this notice to the attention of all who need to know or be aware of it. This may include distribution by:

Trusts to:
CAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:

  • A&E departments
  • All intensive care units
  • All outpatient departments
  • All theatres
  • All wards
  • Clinical or medical engineering departments
  • Medical directors
  • Nursing directors
  • Risk managers
  • Supplies managers

Care Quality Commission (CQC) (England only) to:
The MHRA considers this information to be important to:

  • Care homes providing nursing care (adults)
  • Hospices
  • Hospitals in the independent sector

Primary care trusts to:
CAS liaison officers for onward distribution to all relevant staff including:

  • Community children’s nurses
  • Community hospitals
  • Community midwives
  • Community nurses
  • District nurses
  • Nutritional nurse specialists
  • Palliative care teams

 

If you have any comments or feedback on this Medical Device Alert, please email us at: dts@mhra.gsi.gov.uk

Page last modified: 11 November 2010